登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：688227 证券简称：品高股份 公告编号：2025-048 广州市品高软件股份有限公司 股票交易严重异常波动公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 广州市品高软件股份有限公司（以下简称"公司"或"品高股份"）股票交易连续十个交易日内（2025年11 月12日至11月25日）收盘价格涨幅偏离值累计超过100%，根据《上海证券交易所交易规则》《上海证 券交易所科创板股票异常交易实时监控细则》的有关规定，属于股票交易严重异常波动情形。 经公司自查并发函询证公司控股股东、实际控制人，截至本公告披露日，除公司已披露信息外，公司及 公司控股股东、实际控制人不存在应披露而未披露的重大事项。公司目前生产经营正常，经营情况未发 生重大变化。 重要内容提示： 公司于2025年11月21日在上海证券交易所网站(www.sse.com.cn)披露了《关于控股股东协议转让部分股 份暨权益变动的提示性公告》（公告编号：2025-043）。本次股份协议转让不会导致公司控股股东、 ...

公告显示，本次权益变动信息披露义务人高树华，与公司董事长高晓东因父子关系构成一致行动 人。 中国经济网北京11月23日讯 常山药业(300255.SZ)11月21日晚间发布关于控股股东拟协议转让部分 股份暨权益变动的提示性公告。 持有公司股份280,644,728股，占公司总股本比例30.54%的公司控股股东、实际控制人高树华拟通 过协议转让方式将其持有公司46,000,000股无限售流通股（占公司总股本比例5.0051%）转让给重庆元 素私募证券投资基金管理有限公司（代表"元素致远行千里一号私募证券投资基金"，以下简称"元素基 金"）。本次协议转让过户完成后，元素基金将持有公司股份46,000,000股，占公司目前总股本的 5.0051%，将成为公司持股5%以上股东。 元素基金基于对公司未来持续发展的信心及对公司投资价值的认可，承诺在协议转让完成后的12个 月内不减持所持公司股份。 本次协议转让股份事项需经深圳证券交易所进行合规性审核后方能在中国证券登记结算有限责任公 司深圳分公司办理股份协议转让过户手续。 本次标的股份每股转让价格为人民币46.25元，标的股份转让总价款为人民币212,750万元。 202 ...

Core Viewpoint - The announcement details the completion of a share transfer agreement where the controlling shareholder, Suzhou Keli Decoration Group Co., Ltd., transferred 40 million unrestricted circulating shares, representing 6.71% of the company's total share capital, to Mr. Cui Jianquan. This transfer does not change the actual controller of the company and will not significantly impact its governance structure or ongoing operations [2][5]. Group 1: Share Transfer Details - On November 5, 2025, Keli Decoration Group signed a share transfer agreement to transfer 40,000,000 shares to Mr. Cui Jianquan, which constitutes 6.71% of the company's total share capital [2][3]. - The share transfer has received compliance confirmation from the Shanghai Stock Exchange and the transfer was officially registered on November 20, 2025, with the transfer date being November 19, 2025 [4][6]. - Mr. Cui Jianquan has committed not to reduce his holdings of the transferred shares for 12 months following the completion of the transfer [2][6]. Group 2: Impact and Compliance - The share transfer does not trigger a mandatory tender offer and will not lead to a change in the company's actual controller, nor will it have a significant impact on the company's governance structure or ongoing operations [5][6]. - There are no relationships of associated action between Mr. Cui Jianquan and Keli Decoration Group or its associated parties [5]. - The share transfer complies with relevant regulations and guidelines set forth by the Shanghai Stock Exchange and other regulatory bodies [6].

Core Viewpoint - The controlling shareholder of Suzhou Kolid Decoration Co., Ltd. (ST Kolid) plans to transfer 40 million shares, representing 6.71% of the company's total share capital, to Mr. Cui Jianquan at a price of 6.16 yuan per share, in order to meet its funding needs and introduce new investors [44][46]. Group 1: Share Transfer Details - The share transfer agreement was signed on November 5, 2025, between Suzhou Kolid Group and Mr. Cui Jianquan [44][46]. - The total price for the share transfer amounts to 246.4 million yuan [10][47]. - The transfer price is set at 6.16 yuan per share, which is 95% of the closing price on November 4, 2025 [10][47]. Group 2: Shareholder Structure - Following the transfer, Mr. Cui Jianquan will hold 40,042,493 shares, which will make him a major shareholder with 6.72% of the total share capital [45][46]. - The controlling shareholder, Suzhou Kolid Group, will not change as a result of this transfer, and there will be no adverse effects on the company's governance or ongoing operations [44][45]. Group 3: Compliance and Future Plans - The share transfer is subject to compliance confirmation by the Shanghai Stock Exchange and registration with the China Securities Depository and Clearing Corporation [44][46]. - Mr. Cui Jianquan has committed not to reduce his shareholding within 12 months following the transfer [45][46].

Core Viewpoint - The company reported significant changes in net profit attributable to shareholders, primarily due to a low comparative base, with net profit for the third quarter of 2024 being 70,900 yuan and for the first nine months of 2024 being 228,600 yuan [2][3]. Financial Data Summary - The net profit attributable to shareholders after deducting non-recurring gains and losses for Q3 2024 was 70,900 yuan, showing a notable year-on-year change due to a smaller comparative base [2]. - For the first nine months of 2024, the net profit attributable to shareholders after deducting non-recurring gains and losses was 228,600 yuan, indicating a significant year-on-year percentage change [2]. Non-Recurring Gains and Losses - The company has identified non-recurring gains and losses, but specific amounts and reasons for classification were not detailed in the report [3]. Shareholder Information - The company has engaged in significant contracts, including a satellite communication project worth approximately 112.15 million USD, which is pending payment confirmation [5]. - A framework agreement for a broadband network project in the Democratic Republic of Congo has been signed, with a total budget of 1.5 billion USD, but the project has not yet commenced [5]. - A share transfer agreement was signed for 9,630,000 shares at a price of 22.13 yuan per share, totaling approximately 213.11 million yuan, but the transfer has not yet been registered [6]. - The company plans to issue up to 48,138,658 A-shares to specific investors, aiming to raise up to 1.069 billion yuan, pending regulatory approval [6]. Quarterly Financial Statements - The financial statements for Q3 2025 are unaudited, and the company has not reported any profits from mergers under common control [8].

Core Viewpoint - LabTech Holdings, Inc. plans to transfer 4,145,454 shares of Beijing Laibotai Technology Co., Ltd. to Qingdao Innovation Investment Co., Ltd. at a price of 27.50 CNY per share, representing 6.15% of the total shares, without changing the controlling shareholder or actual controller of the company [2][22]. Summary by Sections Agreement Overview - The transfer agreement was signed on October 20, 2025, with LabTech Holdings transferring 4,145,454 shares at a price of 27.50 CNY per share [4][6]. - After the transfer, Qingdao Innovation Investment will hold 6.15% of the company's total shares [2][4]. Shareholding Situation Before and After Transfer - LabTech Holdings, as a major shareholder, will see its shareholding decrease from 57.48% to 51.33% after the transfer [31][36]. Purpose and Background of the Transfer - The transfer aims to optimize the shareholder structure and introduce investors who recognize the company's development plans and long-term investment value [6][29]. Payment Terms - The total payment for the shares is 113,999,985 CNY, with specific payment schedules outlined, including an initial payment of 30% within five trading days after the transfer confirmation [8][38]. Compliance and Approval - The transfer requires compliance confirmation from the Shanghai Stock Exchange and registration with the China Securities Depository and Clearing Corporation [3][7]. Restrictions on Shareholding - The acquiring party, Qingdao Innovation Investment, commits not to reduce its shareholding within 12 months after the transfer [22][42].

Core Points - The article discusses the transfer of 63,000,000 shares of Shanghai Bairun Investment Holding Group Co., Ltd. from its controlling shareholder Liu Xiaodong to Liu Jianguo, representing 6.01% of the company's total share capital [2][4][6] - The transfer does not trigger a mandatory tender offer and does not constitute a related party transaction, ensuring that the control of the company remains unchanged with Liu Xiaodong as the actual controller [2][8] - Liu Jianguo has committed to not selling the transferred shares for twelve months following the completion of the transfer [2][8] Summary of the Transfer - The share transfer agreement was signed on September 9, 2025, with a total transaction value of RMB 1.47 billion, translating to a price of RMB 23.337 per share [4] - The transfer was completed on October 16, 2025, with the registration of the share transfer confirmed by the China Securities Depository and Clearing Corporation [5] - Post-transfer, Liu Jianguo holds 63,000,000 shares (6.01% of total shares), while Liu Xiaodong retains 362,588,502 shares (34.58% of total shares) [6][8] Regulatory Compliance - The transfer complies with relevant laws and regulations, including the Company Law and Securities Law of the People's Republic of China [7][8] - The transaction does not harm the interests of the company or minority shareholders, nor does it affect the company's governance structure or ongoing operations [8]

Core Viewpoint - The stock of ZhenDe Medical has experienced abnormal trading fluctuations, with a cumulative closing price deviation exceeding 20% over three consecutive trading days [1] Group 1: Stock Trading and Transfer - The controlling shareholder, Zhejiang ZhenDe, along with its wholly-owned subsidiary, Xuchang Garden, is transferring a total of 13,322,560 unrestricted circulating shares, accounting for 5.00% of the company's total share capital [1] - The shares are being transferred at a price of RMB 26.74 per share, resulting in a total transaction value of RMB 356 million [1] - The transfer is subject to compliance review by the Shanghai Stock Exchange and must complete the share transfer registration with the China Securities Depository and Clearing Corporation Limited, Shanghai Branch [1] Group 2: Uncertainties and Conditions - The completion of this transaction is uncertain due to the existence of pledges on the transferred shares, which must be resolved before the transfer can be finalized [1]

Group 1 - The company has completed the election of the ninth board of directors, with a total of 9 members, including 6 non-independent directors and 3 independent directors [10][11] - The election results for the non-independent directors were unanimous, with 8 votes in favor and no opposition or abstentions [1][2][3][4] - The independent director candidates, Lin Yan, Ba Qi, and Peng Guifen, have been nominated, with their qualifications pending approval from the Shenzhen Stock Exchange [4][11][22][24] Group 2 - The company will hold its second extraordinary general meeting of 2025 on October 16, 2025, to review the election of the new board members [6][26] - The voting for the board members will be conducted using a cumulative voting system, allowing shareholders to allocate their votes among the candidates [34][39] - The company has ensured compliance with relevant laws and regulations regarding the election process and the qualifications of the board members [10][55]

Core Viewpoint - The report outlines a shareholding change involving Beijing Anbotong Technology Co., Ltd., where Nanjing Yisan Yi Private Fund Management Co., Ltd. will acquire 4,304,000 shares, representing 5.6% of the company's total share capital through a private agreement transfer [1][6][12]. Group 1: Shareholding Change Details - The share transfer is conducted via a private agreement, requiring approval from the Shanghai Stock Exchange and the China Securities Depository and Clearing Corporation [2][8]. - The total payment for the shares is RMB 309,888,000, with a per-share price of RMB 72.00 [6][7]. - The payment structure includes an initial payment of RMB 50 million, followed by 40% of the total price after certain conditions are met, and the remaining balance within ten working days after the share transfer [7][8]. Group 2: Information Disclosure Obligations - The information disclosure obligations have been fulfilled according to relevant laws and regulations, ensuring no false statements or omissions are present in the report [2][9]. - The report confirms that the acquiring party, Nanjing Yisan Yi, had no prior ownership in Anbotong before this transaction [5][12]. - The acquiring party does not have any consistent action relationship with other parties and does not hold more than 5% in any other listed companies [4][9]. Group 3: Future Plans and Compliance - The acquiring party has no plans to increase or decrease its shareholding in the next 12 months, adhering to legal disclosure requirements for any future changes [4][12]. - The shares involved in this transaction are unrestricted and free from any encumbrances [8].